The pulsation spectrum of VX Hydrae

We present the results of a two-year, multisite observing campaign investigating the high-amplitude delta Scuti star VX Hydrae during the 2006 and 2007 observing seasons. The final data set consists of nearly 8500 V-band observations spanning HJD 2453763.6 to 2454212.7 (2006 January 28 to 2007 April 22). Separate analyses of the two individual seasons of data yield 25 confidently-detected frequencies common to both data sets, of which two are pulsation modes, and the remaining 23 are Fourier harmonics or beat frequencies of these two modes. The 2006 data set had five additional frequencies with amplitudes less than 1.5 mmag, and the 2007 data had one additional frequency. Analysis of the full 2006-2007 data set yields 22 of the 25 frequencies found in the individual seasons of data. There are no significant peaks in the spectrum other than these between 0 and 60 c/d. The frequencies of the two main pulsation modes derived from the 2006 and 2007 observing seasons individually do not differ at the level of 3-sigma, and thus we find no conclusive evidence for period change over the span of these observations. However, the amplitude of f(1) = 5.7898 c/d changed significantly between the two seasons, while the amplitude of f(0) = 4.4765 c/d remained constant; amplitudes of the Fourier harmonics and beat frequencies of f(1) also changed. Similar behavior was seen in the 1950s, and it is clear that VX Hydrae undergoes significant amplitude changes over time.Comment: 14 pages, 5 figures, published in Publications of the Astronomical Society of the Pacific, v.121, p.1076 (October 2009

Liquid phase epitaxy and spectroscopic investigation of optically active KYb(WO4)2 thin layers

In recent years, Yb3+ has attracted much attention as an activating ion because of its small quantum defect for laser emission from 2F5/2 to 2F7/2 at ~1.03 µm, which provides high efficiency and reduced heat generation. A promising material for Yb3+ lasers is KYb(WO4)2 (KYbW) [1]. It can be grown from high-temperature solutions [2]. A suitable substrate material for the growth of single-crystalline layers with thicknesses in the range of the absorption length of ~13 µm at 981 nm is KY(WO4)2 (KYW).\ud We demonstrate the liquid phase epitaxy (LPE) of KYbW layers at start temperatures as low as 520°C from the chloride solvent KCl-NaCl-CsCl. This temperature is favorable in order to decrease the thermal stresses due to the differences in the thermal expansion coefficients of substrate and layer. Moreover, the choice of [010]-oriented KYW substrates bypasses the large difference in the thermal expansion coefficient along the [010] direction. Our spectroscopic investigations show that the fluorescence lifetime of ~250 µs measured in our LPE-grown KYbW layers is dominated by radiative decay and is very similar to that measured in top-seeded-solution-grown bulk samples [2]. Fast energy migration among the Yb3+ ions and energy transfer to small amounts of Tm3+ and Er3+ ions present in the YbCl3 reagent lead to visible upconversion luminescence in the layers under 981-nm excitation.\ud \ud [1] P. Klopp, U. Griebner, V. Petrov, X. Mateos, M.A. Bursukova, M.C. Pujol, R. Solé, J. Gavaldà, M. Aguiló, F. Güell, J. Massons, T. Kirilov, F. Díaz, Appl. Phys. B 2002, 74, 185\ud [2] M.C. Pujol, M.A. Bursukova, F. Güell, X. Mateos, R. Solé, J. Gavaldà, M. Aguiló, J. Massons, F. Díaz, P. Klopp, U. Griebner, V. Petrov, Phys. Rev. B 2002, 65, 16512

Liquid phase epitaxy and optical investigation of KYb(WO4)2 thin layers

In recent years, Yb3+ has attracted much attention as an activating ion because of its small quantum defect for laser emission from 2F5/2 to 2F7/2 at ~1.03 µm [1], which provides high efficiency and reduced heat generation. Of high practical interest is the thin-disk laser concept [2], which possesses a tremendous advantage over rod lasers because of its axial-cooling approach and consequent weak thermal lensing and good beam quality.\ud A promising material for Yb3+ thin-disk lasers is KYb(WO4)2 (KYbW) [3]. It can be grown from high-temperature solutions [4]. Nevertheless, the growth of high-quality, single-crystalline layers with thickness in the range of the absorption length of ~13 µm at 981 nm has as yet not been reported. A suitable substrate material is KY(WO4)2 (KYW), but the relatively large differences in the thermal expansion coefficients between KYW and KYbW along the [100], [001], and especially [010] directions [5] favor low temperatures for the hetero-epitaxial growth.\ud For the first time, we demonstrate liquid phase epitaxy (LPE) of KYbW layers. The layers were grown at start temperatures as low as 520°C, which is favorable in order to decrease the thermal stresses due to the differences in the thermal expansion coefficients of substrate and layer. Moreover, the choice of [010]-oriented substrates bypasses the large difference in the thermal expansion coefficient along the [010] direction. KY1-xYbx(WO4)2 layers with varying x = 0.03-1.00 were grown by LPE. The chloride solvent consisted of the eutectic composition [6] 24.4 mol.% KCl, 30.4 mol.% NaCl, and 42.2 mol.% CsCl. The growth temperature spanned the range from 580 to 500°C and the cooling rate was 0.67-1.00 Kh-1. Crack-free, transparent KYbW layers were grown on (010) substrates.\ud Spectroscopic investigations have shown that the lifetime of ~250 µs measured in our LPE-grown KYbW layers is dominated by radiative decay and is very similar to that measured in top-seeded-solution-grown bulk samples [4]. Fast energy migration among the Yb3+ ions and energy transfer to small amounts of Tm3+ and Er3+ ions present in the YbCl3 reagent lead to visible upconversion luminescence in the layers under 981-nm excitation.\ud \ud [1] T.Y. Fan, IEEE J. Quantum Electron. 29, 1457 (1993).\ud [2] A. Giesen, H. Hügel, A. Voss, K. Wittig, U. Brauch, H. Opower, Appl. Phys. B 58, 365 (1994).\ud [3] P. Klopp, U. Griebner, V. Petrov, X. Mateos, M.A. Bursukova, M.C. Pujol, R. Solé, J. Gavaldà, M. Aguiló, F. Güell, J. Massons, T. Kirilov, F. Díaz, Appl. Phys. B 74, 185 (2002).\ud [4] M.C. Pujol, M.A. Bursukova, F. Güell, X. Mateos, R. Solé, J. Gavaldà, M. Aguiló, J. Massons, F. Díaz, P. Klopp, U. Griebner, V. Petrov, Phys. Rev. B 65, 165121 (2002).\ud [5] M.C. Pujol, X. Mateos, R. Solé, J. Massons, J. Gavaldà, F. Díaz, M. Aguiló, Mater. Sci. Forum 378-381, 710 (2001).\ud [6] D. Ehrentraut, M. Pollnau, S. Kück, Appl. Phys. B 75, 59 (2002)

Randomized trial of polychromatic blue-enriched light for circadian phase shifting, melatonin suppression, and alerting responses.

Wavelength comparisons have indicated that circadian phase-shifting and enhancement of subjective and EEG-correlates of alertness have a higher sensitivity to short wavelength visible light. The aim of the current study was to test whether polychromatic light enriched in the blue portion of the spectrum (17,000 K) has increased efficacy for melatonin suppression, circadian phase-shifting, and alertness as compared to an equal photon density exposure to a standard white polychromatic light (4000 K). Twenty healthy participants were studied in a time-free environment for 7 days. The protocol included two baseline days followed by a 26-h constant routine (CR1) to assess initial circadian phase. Following CR1, participants were exposed to a full-field fluorescent light (1 × 10 14 photons/cm 2 /s, 4000 K or 17,000 K, n = 10/condition) for 6.5 h during the biological night. Following an 8 h recovery sleep, a second 30-h CR was performed. Melatonin suppression was assessed from the difference during the light exposure and the corresponding clock time 24 h earlier during CR1. Phase-shifts were calculated from the clock time difference in dim light melatonin onset time (DLMO) between CR1 and CR2. Blue-enriched light caused significantly greater suppression of melatonin than standard light ((mean ± SD) 70.9 ± 19.6% and 42.8 ± 29.1%, respectively, p \u3c 0.05). There was no significant difference in the magnitude of phase delay shifts. Blue-enriched light significantly improved subjective alertness (p \u3c 0.05) but no differences were found for objective alertness. These data contribute to the optimization of the short wavelength-enriched spectra and intensities needed for circadian, neuroendocrine and neurobehavioral regulation

Use of QSARs in international decision-making frameworks to predict health effects of chemical substances

This article is a review of the use of quantitative (and qualitative) structure-activity relationships (QSARs and SARs) by regulatory agencies and authorities to predict acute toxicity, mutagenicity, carcinogenicity, and other health effects. A number of SAR and QSAR applications, by regulatory agencies and authorities, are reviewed. These include the use of simple QSAR analyses, as well as the use of multivariate QSARs, and a number of different expert system approaches

The Transiting System GJ1214: High-Precision Defocused Transit Observations and a Search for Evidence of Transit Timing Variation

Aims: We present 11 high-precision photometric transit observations of the transiting super-Earth planet GJ1214b. Combining these data with observations from other authors, we investigate the ephemeris for possible signs of transit timing variations (TTVs) using a Bayesian approach. Methods: The observations were obtained using telescope-defocusing techniques, and achieve a high precision with random errors in the photometry as low as 1mmag per point. To investigate the possibility of TTVs in the light curve, we calculate the overall probability of a TTV signal using Bayesian methods. Results: The observations are used to determine the photometric parameters and the physical properties of the GJ1214 system. Our results are in good agreement with published values. Individual times of mid-transit are measured with uncertainties as low as 10s, allowing us to reduce the uncertainty in the orbital period by a factor of two. Conclusions: A Bayesian analysis reveals that it is highly improbable that the observed transit times is explained by TTV, when compared with the simpler alternative of a linear ephemeris.Comment: Submitted to A&

Ornithine Decarboxylase mRNA is Stabilized in an mTORC1-dependent Manner in Ras-transformed Cells

Upon Ras activation, ODC (ornithine decarboxylase) is markedly induced, and numerous studies suggest that ODC expression is controlled by Ras effector pathways. ODC is therefore a potential target in the treatment and prevention of Ras-driven tumours. In the present study we compared ODC mRNA translation profiles and stability in normal and Ras12V-transformed RIE-1 (rat intestinal epithelial) cells. While translation initiation of ODC increased modestly in Ras12V cells, ODC mRNA was stabilized 8-fold. Treatment with the specific mTORC1 [mTOR (mammalian target of rapamycin) complex 1] inhibitor rapamycin or siRNA (small interfering RNA) knockdown of mTOR destabilized the ODC mRNA, but rapamycin had only a minor effect on ODC translation initiation. Inhibition of mTORC1 also reduced the association of the mRNA-binding protein HuR with the ODC transcript. We have shown previously that HuR binding to the ODC 3′UTR (untranslated region) results in significant stabilization of the ODC mRNA, which contains several AU-rich regions within its 3′UTR that may act as regulatory sequences. Analysis of ODC 3′UTR deletion constructs suggests that cis-acting elements between base 1969 and base 2141 of the ODC mRNA act to stabilize the ODC transcript. These experiments thus define a novel mechanism of ODC synthesis control. Regulation of ODC mRNA decay could be an important means of limiting polyamine accumulation and subsequent tumour development

Outcomes and costs of primary care surveillance and intervention for overweight or obese children: the LEAP 2 randomised controlled trial

addresses: Royal Children's Hospital, Murdoch Childrens Research Institute and University of Melbourne, Parkville, Vic 3052, Australia. [email protected]: PMCID: PMC2737607types: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov'tCopyright © 2009 by the BMJ Publishing Group Ltd. This articles was first published in: BMJ, 2009, Vol. 339, pp. b3308 -To determine whether ascertainment of childhood obesity by surveillance followed by structured secondary prevention in primary care improved outcomes in overweight or mildly obese children

CELL DEATH AND AUTOPHAGY: CYTOKINES, DRUGS, AND NUTRITIONAL FACTORS

Cellsmay use multiple pathways to commit suicide. In certain contexts, dying cells generate large amounts of autophagic vacuoles and clear large proportions of their cytoplasm, before they finally die, as exemplified by the treatment of human mammary carcinoma cells with the anti-estrogen tamoxifen (TAM, ≤1 M). Protein analysis during autophagic cell death revealed distinct proteins of the nuclear fraction including GST- and some proteasomal subunit constituents to be affected during autophagic cell death. Depending on the functional status of caspase-3, MCF-7 cells may switch between autophagic and apoptotic features of cell death [Fazi, B., Bursch,W., Fimia, G.M., Nardacci R., Piacentini, M., Di Sano, F., Piredda, L., 2008. Fenretinide induces autophagic cell death in caspase-defective breast cancer cells. Autophagy 4(4), 435–441]. Furthermore, the self-destruction of MCF-7 cells was found to be completed by phagocytosis of cell residues [Petrovski, G., Zahuczky, G., Katona, K., Vereb, G., Martinet,W., Nemes, Z., Bursch,W., Fésüs, L., 2007. Clearance of dying autophagic cells of different origin by professional and non-professional phagocytes. Cell Death Diff. 14 (6), 1117–1128]. Autophagy also constitutes a cell’s strategy of defense upon cell damage by eliminating damaged bulk proteins/organelles. This biological condition may be exemplified by the treatment of MCF-7 cells with a necrogenic TAM-dose (10 M), resulting in the lysis of almost all cells within 24 h. However, a transient (1 h) challenge of MCF-7 cells with the same dose allowed the recovery of cells involving autophagy. Enrichment of chaperones in the insoluble cytoplasmic protein fraction indicated the formation of aggresomes, a potential trigger for autophagy. In a further experimental model HL60 cells were treated with TAM, causing dose-dependent distinct responses: 1–5 MTAM, autophagy predominant; 7–9 M, apoptosis predominant; 15 M, necrosis. These phenomena might be attributed to the degree of cell damage caused by tamoxifen, either by generating ROS, increasing membrane fluidity or forming DNA-adducts. Finally, autophagy constitutes a cell’s major adaptive (survival) strategy in response to metabolic challenges such as glucose or amino acid deprivation, or starvation in general. Notably, the role of autophagy appears not to be restricted to nutrient recycling in order to maintain energy supply of cells and to adapt cell(organ) size to given physiological needs. For instance, using a newly established hepatoma cell line HCC-1.2, amino acid and glucose deprivation revealed a pro-apoptotic activity, additive to TGF- 1. The proapoptotic action of glucose deprivation was antagonized by 2-deoxyglucose, possibly by stabilizing the mitochondrial membrane involving the action of hexokinase II. These observations suggest that signaling cascades steering autophagy appear to provide links to those regulating cell number. Taken together, our data exemplify that a given cell may flexibly respond to type and degree of (micro)environmental changes or cell death stimuli; a cell’s response may shift gradually from the elimination of damaged proteins by autophagy and the recovery to autophagic or apoptotic pathways of cell death, the failure of which eventually may result in necrosis